Sarepta Therapeutics (NasdaqGS:SRPT) recently provided updates that may have influenced its stock performance. The announcement of a safety update for ELEVIDYS, concerning severe side effects and a ...

The agency is considering further regulatory action after a second Duchenne patient died from acute liver failure less than two months after receiving the gene therapy.

HIVE Digital Technologies Ltd. (HIVE) on Wednesday reported a loss of $52.9 million in its fiscal fourth quarter. On a per-share basis, the Vancouver, British Columbia-based company said it had a loss ...

The FDA said yesterday that it is investigating the deaths from liver failure of two non-ambulatory boys with Duchenne ...

Bumble stock up after JPMorgan note. Analyst surprised by workforce reduction, but raised revenue outlook despite declining downloads and stagnant users.